✨ Free AI Report
Niagen Bioscience, Inc. (formerly ChromaDex Corp.): Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Niagen Bioscience, Inc. (formerly ChromaDex Corp.)
Research Preview

Niagen Bioscience, Inc. (formerly ChromaDex Corp.): Business Overview, Financials & Competitive Analysis

ChromaDex/Niagen is a global bioscience company dedicated to healthy aging, pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ p...

Analyst-debate audio for Niagen Bioscience, Inc. (formerly ChromaDex Corp.)

AskCyborg analysts argue the bull and bear cases for Niagen Bioscience, Inc. (formerly ChromaDex Corp.) across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Niagen Bioscience, Inc. (formerly ChromaDex Corp.) OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Established NAD+ leader with growing consumer demand and clinical validation, but execution and scaling risks remain in a...

Read the full analyst-debate transcript →
Industry NAD+ and healthy aging supplements
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 6, 2026
AI-Verified Research
30+ Page Report

Get the Latest Niagen Bioscience, Inc. (formerly ChromaDex Corp.) Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Niagen Bioscience, Inc. (formerly ChromaDex Corp.) Overview

Pro stress-test →

ChromaDex/Niagen is a global bioscience company dedicated to healthy aging, pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Tru Niagen® is positioned as the number one healthy-aging NAD+ supplement in the United States.

Strategic Profile

Pro stress-test →

The company operates through three segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the majority of revenue from Consumer Products. The company has partnered with multiple research institutions including the National Institutes of Health and Northwestern University Feinberg School of Medicine to study nicotinamide riboside benefits.

Competitive Landscape

Pro stress-test →

Niagen competes in the growing healthy aging and NAD+ supplement market against established supplement brands and emerging longevity companies. Key rivals include Elysium Health (Basis NAD+ booster), other NAD+ precursor manufacturers, and broader premium supplement makers targeting aging consumers. The market is emerging but not yet commoditized, and Niagen's patent-protected formulation and clinical research partnerships provide defensibility.

Industry Context

Niagen Bioscience, Inc. (formerly ChromaDex Corp.) operates in NAD+ and healthy aging supplements.

Key facts

Founded: 1999 · Headquarters: Los Angeles, US · Employees: Unknown · Revenue: $31.5M (Q1 2026) · Market cap: $230.79M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Niagen Bioscience, Inc. (formerly ChromaDex Corp.).

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Niagen Bioscience, Inc. (formerly ChromaDex Corp.) has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

BasisNAD+ booster supplement competitor in healthy agingTru NiagenFlagship NAD+ precursor supplement using patented nicotinamide riboside (NR)NádNAD+ supplement offering NR and NMN variants for healthy agingNAD+ ProPremium NAD+ precursor supplement targeting aging consumers

Compare Niagen Bioscience, Inc. (formerly ChromaDex Corp.) with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Niagen Bioscience, Inc. (formerly ChromaDex Corp.) operates in NAD+ and healthy aging supplements. See how the rest of the sector scores on the Cyborg framework.

Browse NAD+ and healthy aging supplements research →
NEW · MCP server

Ask your AI assistant about Niagen Bioscience, Inc. (formerly ChromaDex Corp.)

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Niagen Bioscience, Inc. (formerly ChromaDex Corp.) and its top competitor on Cyborg Score”
“What did Niagen Bioscience, Inc. (formerly ChromaDex Corp.) do this quarter?”
“Is Niagen Bioscience, Inc. (formerly ChromaDex Corp.) a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Niagen Bioscience, Inc. (formerly ChromaDex Corp.) do?+
ChromaDex/Niagen is a global bioscience company dedicated to healthy aging, pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ p...
What is Niagen Bioscience, Inc. (formerly ChromaDex Corp.)'s Cyborg Score?+
Niagen Bioscience, Inc. (formerly ChromaDex Corp.) has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Niagen Bioscience, Inc. (formerly ChromaDex Corp.)'s main competitors?+
Named competitors include Basis, Tru Niagen, Nád, NAD+ Pro. The full competitive landscape is in the AskCyborg report.
How can I get the full Niagen Bioscience, Inc. (formerly ChromaDex Corp.) research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Niagen Bioscience, Inc. (formerly ChromaDex Corp.) research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Niagen Bioscience, Inc. (formerly ChromaDex Corp.) over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual